TY - JOUR
T1 - Exploring the genetics of airflow limitation in lung function across the lifespan – a polygenic risk score study
AU - Hernandez-Pacheco, Natalia
AU - Kilanowski, Anna
AU - Kumar, Ashish
AU - CADSET Clinical Research Collaboration of the European Respiratory Society
AU - Curtin, John A.
AU - Olvera, Núria
AU - Kress, Sara
AU - Bertels, Xander
AU - Lahousse, Lies
AU - Bhatta, Laxmi
AU - Granell, Raquel
AU - Marí, Sergi
AU - Bilbao, Jose Ramon
AU - Sun, Yidan
AU - Tingskov Pedersen, Casper Emil
AU - Karramass, Tarik
AU - Thiering, Elisabeth
AU - Dardani, Christina
AU - Kebede Merid, Simon
AU - Wang, Gang
AU - Hallberg, Jenny
AU - Koch, Sarah
AU - Garcia-Aymerich, Judith
AU - Esplugues, Ana
AU - Torrent, Maties
AU - Ibarluzea, Jesus
AU - Lowe, Lesley
AU - Simpson, Angela
AU - Gehring, Ulrike
AU - Vermeulen, Roel C.H.
AU - Roberts, Graham
AU - Bergström, Anna
AU - Vonk, Judith M.
AU - Felix, Janine F.
AU - Duijts, Liesbeth
AU - Bønnelykke, Klaus
AU - Timpson, Nic
AU - Brusselle, Guy
AU - Brumpton, Ben M.
AU - Langhammer, Arnulf
AU - Turner, Stephen
AU - Holloway, John W.
AU - Arshad, Syed Hasan
AU - Ullah, Anhar
AU - Custovic, Adnan
AU - Cullinan, Paul
AU - Murray, Clare S.
AU - van den Berge, Maarten
AU - Kull, Inger
AU - Schikowski, Tamara
AU - Wedzicha, Jadwiga A.
N1 - Publisher Copyright: © 2024 The Author(s)
PY - 2024/9
Y1 - 2024/9
N2 - Background: Chronic obstructive pulmonary disease (COPD) is caused by interactions between many factors across the life course, including genetics. A proportion of COPD may be due to reduced lung growth in childhood. We hypothesized that a polygenic risk score (PRS) for COPD is associated with lower lung function already in childhood and up to adulthood. Methods: A weighted PRS was calculated based on the 82 association signals (p ≤ 5 × 10−8) revealed by the largest GWAS of airflow limitation (defined as COPD) to date. This PRS was tested in association with lung function measures (FEV1, FVC, and FEV1/FVC) in subjects aged 4–50 years from 16 independent cohorts participating in the Chronic Airway Diseases Early Stratification (CADSET) Clinical Research Collaboration. Age-stratified meta-analyses were conducted combining the results from each cohort (n = 45,406). These findings were validated in subjects >50 years old. Findings: We found significant associations between the PRS for airflow limitation and: (1) lower pre-bronchodilator FEV1/FVC from school age (7–10 years; β: −0.13 z-scores per one PRS z-score increase [–0.15, −0.11], q-value = 7.04 × 10−53) to adulthood (41–50 years; β: −0.16 [–0.19, −0.13], q-value = 1.31 × 10−24); and (2) lower FEV1 (from school age: 7–10 years; β: −0.07 [–0.09, −0.05], q-value = 1.65 × 10−9, to adulthood: 41–50 years; β: −0.17 [–0.20, −0.13], q-value = 4.48 x 10−20). No effect modification by smoking, sex, or a diagnosis of asthma was observed. Interpretation: We provide evidence that a higher genetic risk for COPD is linked to lower lung function from childhood onwards. Funding: This study was supported by CADSET, a Clinical Research Collaboration of the European Respiratory Society.
AB - Background: Chronic obstructive pulmonary disease (COPD) is caused by interactions between many factors across the life course, including genetics. A proportion of COPD may be due to reduced lung growth in childhood. We hypothesized that a polygenic risk score (PRS) for COPD is associated with lower lung function already in childhood and up to adulthood. Methods: A weighted PRS was calculated based on the 82 association signals (p ≤ 5 × 10−8) revealed by the largest GWAS of airflow limitation (defined as COPD) to date. This PRS was tested in association with lung function measures (FEV1, FVC, and FEV1/FVC) in subjects aged 4–50 years from 16 independent cohorts participating in the Chronic Airway Diseases Early Stratification (CADSET) Clinical Research Collaboration. Age-stratified meta-analyses were conducted combining the results from each cohort (n = 45,406). These findings were validated in subjects >50 years old. Findings: We found significant associations between the PRS for airflow limitation and: (1) lower pre-bronchodilator FEV1/FVC from school age (7–10 years; β: −0.13 z-scores per one PRS z-score increase [–0.15, −0.11], q-value = 7.04 × 10−53) to adulthood (41–50 years; β: −0.16 [–0.19, −0.13], q-value = 1.31 × 10−24); and (2) lower FEV1 (from school age: 7–10 years; β: −0.07 [–0.09, −0.05], q-value = 1.65 × 10−9, to adulthood: 41–50 years; β: −0.17 [–0.20, −0.13], q-value = 4.48 x 10−20). No effect modification by smoking, sex, or a diagnosis of asthma was observed. Interpretation: We provide evidence that a higher genetic risk for COPD is linked to lower lung function from childhood onwards. Funding: This study was supported by CADSET, a Clinical Research Collaboration of the European Respiratory Society.
UR - http://www.scopus.com/inward/record.url?scp=85203075860&partnerID=8YFLogxK
U2 - 10.1016/j.eclinm.2024.102731
DO - 10.1016/j.eclinm.2024.102731
M3 - Article
AN - SCOPUS:85203075860
SN - 2589-5370
VL - 75
JO - EClinicalMedicine
JF - EClinicalMedicine
M1 - 102731
ER -